Nestle To Buy Pfizer's Infant-Nutrition Line
April 23, 2012 3:04:00 am
Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Swiss food and drink giant Nestle announced a deal Monday to acquire Pfizer Inc.'s infant-nutrition business for $11.85 billion in a bid to boost sales in emerging markets. Before the announcement, Nestle already had the largest share of the global baby-formula market at just under 20 percent.
Copyright 2012 National Public Radio. To see more, visit http://www.npr.org/.